vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and ZIFF DAVIS, INC. (ZD). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $406.7M, roughly 1.2× ZIFF DAVIS, INC.). ZIFF DAVIS, INC. runs the higher net margin — 0.1% vs -10.1%, a 10.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -1.5%). ZIFF DAVIS, INC. produced more free cash flow last quarter ($157.8M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 13.7%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Ziff Davis, Inc. is an American digital media and Internet company. Founded in 1927 by William Bernard Ziff Sr. and Bernard George Davis, the company primarily owns technology- and health-oriented media websites, online shopping-related services, Internet connectivity services, gaming and entertainment brands, and cybersecurity and martech tools. Previously, the company was predominantly a publisher of hobbyist magazines.

CLOV vs ZD — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.2× larger
CLOV
$487.7M
$406.7M
ZD
Growing faster (revenue YoY)
CLOV
CLOV
+46.2% gap
CLOV
44.7%
-1.5%
ZD
Higher net margin
ZD
ZD
10.2% more per $
ZD
0.1%
-10.1%
CLOV
More free cash flow
ZD
ZD
$226.7M more FCF
ZD
$157.8M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
13.7%
ZD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
ZD
ZD
Revenue
$487.7M
$406.7M
Net Profit
$-49.3M
$370.0K
Gross Margin
85.9%
Operating Margin
-10.1%
21.2%
Net Margin
-10.1%
0.1%
Revenue YoY
44.7%
-1.5%
Net Profit YoY
-123.2%
-99.4%
EPS (diluted)
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ZD
ZD
Q4 25
$487.7M
$406.7M
Q3 25
$496.6M
$363.7M
Q2 25
$477.6M
$352.2M
Q1 25
$462.3M
$328.6M
Q4 24
$337.0M
$412.8M
Q3 24
$331.0M
$353.6M
Q2 24
$356.3M
$320.8M
Q1 24
$346.9M
$314.5M
Net Profit
CLOV
CLOV
ZD
ZD
Q4 25
$-49.3M
$370.0K
Q3 25
$-24.4M
$-3.6M
Q2 25
$-10.6M
$26.3M
Q1 25
$-1.3M
$24.2M
Q4 24
$-22.1M
$64.1M
Q3 24
$-9.2M
$-48.6M
Q2 24
$7.4M
$36.9M
Q1 24
$-19.2M
$10.6M
Gross Margin
CLOV
CLOV
ZD
ZD
Q4 25
85.9%
Q3 25
85.4%
Q2 25
86.1%
Q1 25
85.6%
Q4 24
87.1%
Q3 24
24.5%
85.5%
Q2 24
30.3%
84.4%
Q1 24
23.6%
85.4%
Operating Margin
CLOV
CLOV
ZD
ZD
Q4 25
-10.1%
21.2%
Q3 25
-4.9%
7.8%
Q2 25
-2.2%
9.5%
Q1 25
-0.3%
10.7%
Q4 24
-6.4%
19.0%
Q3 24
-2.7%
-8.3%
Q2 24
2.0%
8.9%
Q1 24
-6.5%
11.4%
Net Margin
CLOV
CLOV
ZD
ZD
Q4 25
-10.1%
0.1%
Q3 25
-4.9%
-1.0%
Q2 25
-2.2%
7.5%
Q1 25
-0.3%
7.4%
Q4 24
-6.6%
15.5%
Q3 24
-2.8%
-13.7%
Q2 24
2.1%
11.5%
Q1 24
-5.5%
3.4%
EPS (diluted)
CLOV
CLOV
ZD
ZD
Q4 25
$0.06
Q3 25
$-0.09
Q2 25
$0.62
Q1 25
$0.56
Q4 24
$1.53
Q3 24
$-1.11
Q2 24
$0.77
Q1 24
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ZD
ZD
Cash + ST InvestmentsLiquidity on hand
$78.3M
$607.0M
Total DebtLower is stronger
$866.5M
Stockholders' EquityBook value
$308.7M
$1.8B
Total Assets
$541.0M
$3.7B
Debt / EquityLower = less leverage
0.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ZD
ZD
Q4 25
$78.3M
$607.0M
Q3 25
$503.4M
Q2 25
$457.3M
Q1 25
$431.0M
Q4 24
$194.5M
$505.9M
Q3 24
$288.0M
$386.1M
Q2 24
$254.8M
$687.2M
Q1 24
$208.3M
$751.2M
Total Debt
CLOV
CLOV
ZD
ZD
Q4 25
$866.5M
Q3 25
Q2 25
Q1 25
Q4 24
$864.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
ZD
ZD
Q4 25
$308.7M
$1.8B
Q3 25
$340.9M
$1.8B
Q2 25
$344.2M
$1.8B
Q1 25
$336.1M
$1.8B
Q4 24
$341.1M
$1.8B
Q3 24
$342.2M
$1.8B
Q2 24
$324.9M
$1.9B
Q1 24
$292.5M
$1.9B
Total Assets
CLOV
CLOV
ZD
ZD
Q4 25
$541.0M
$3.7B
Q3 25
$559.7M
$3.5B
Q2 25
$575.0M
$3.5B
Q1 25
$583.7M
$3.5B
Q4 24
$580.7M
$3.7B
Q3 24
$653.0M
$3.4B
Q2 24
$674.2M
$3.7B
Q1 24
$671.8M
$3.7B
Debt / Equity
CLOV
CLOV
ZD
ZD
Q4 25
0.49×
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ZD
ZD
Operating Cash FlowLast quarter
$-66.9M
$191.1M
Free Cash FlowOCF − Capex
$-69.0M
$157.8M
FCF MarginFCF / Revenue
-14.1%
38.8%
Capex IntensityCapex / Revenue
0.4%
8.2%
Cash ConversionOCF / Net Profit
516.44×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$287.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ZD
ZD
Q4 25
$-66.9M
$191.1M
Q3 25
$12.1M
$138.3M
Q2 25
$5.4M
$57.1M
Q1 25
$-16.3M
$20.6M
Q4 24
$34.8M
$158.2M
Q3 24
$50.0M
$106.0M
Q2 24
$44.8M
$50.6M
Q1 24
$25.9M
$75.6M
Free Cash Flow
CLOV
CLOV
ZD
ZD
Q4 25
$-69.0M
$157.8M
Q3 25
$11.4M
$108.2M
Q2 25
$4.8M
$26.9M
Q1 25
$-16.5M
$-5.0M
Q4 24
$33.3M
$131.1M
Q3 24
$49.6M
$80.1M
Q2 24
$44.4M
$25.1M
Q1 24
$25.5M
$47.4M
FCF Margin
CLOV
CLOV
ZD
ZD
Q4 25
-14.1%
38.8%
Q3 25
2.3%
29.7%
Q2 25
1.0%
7.6%
Q1 25
-3.6%
-1.5%
Q4 24
9.9%
31.8%
Q3 24
15.0%
22.7%
Q2 24
12.5%
7.8%
Q1 24
7.3%
15.1%
Capex Intensity
CLOV
CLOV
ZD
ZD
Q4 25
0.4%
8.2%
Q3 25
0.1%
8.3%
Q2 25
0.1%
8.6%
Q1 25
0.0%
7.8%
Q4 24
0.5%
6.6%
Q3 24
0.1%
7.3%
Q2 24
0.1%
8.0%
Q1 24
0.1%
8.9%
Cash Conversion
CLOV
CLOV
ZD
ZD
Q4 25
516.44×
Q3 25
Q2 25
2.17×
Q1 25
0.85×
Q4 24
2.47×
Q3 24
Q2 24
6.04×
1.37×
Q1 24
7.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

ZD
ZD

Health And Wellness$114.8M28%
Technology And Shopping$108.9M27%
Cybersecurity And Martech Segment$70.9M17%
Connectivity$60.3M15%
Gaming And Entertainment$51.7M13%
Subscription And Licensing$2.9M1%

Related Comparisons